Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals

New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges

(2014) Jean–Michel Pawlotsky   GASTROENTEROLOGY

Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis

(2014) Christophe Hézode et al.   GASTROENTEROLOGY

A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy

(2014) James R. Burton et al.   JOURNAL OF HEPATOLOGY

O114 RESULTS OF THE PHASE 2 STUDY M12-999: INTERFERON-FREE REGIMEN OF ABT-450/R/ABT-267 + ABT-333 + RIBAVIRIN IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HCV GENOTYPE 1 INFECTION

(2014) P. Kwo et al.   JOURNAL OF HEPATOLOGY

O62 SOFOSBUVIR COMPASSIONATE USE PROGRAM FOR PATIENTS WITH SEVERE RECURRENT HEPATITIS C INCLUDING FIBROSING CHOLESTATIC HEPATITIS FOLLOWING LIVER TRANSPLANTATION

(2014) X. Forns et al.   JOURNAL OF HEPATOLOGY

O68 SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HCV WITH CIRRHOSIS AND PORTAL HYPERTENSION WITH AND WITHOUT DECOMPENSATION: EARLY VIROLOGIC RESPONSE AND SAFETY

(2014) N. Afdhal et al.   JOURNAL OF HEPATOLOGY

Treatment of Recurrent Genotype 1 Hepatitis C Post-Liver Transplantation: Single Center Experience with Telaprevir-Based Triple Therapy

(2014) C. Werner et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C

(2013) R. J. Fontana et al.   AMERICAN JOURNAL OF TRANSPLANTATION

EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

(2013)   JOURNAL OF HEPATOLOGY

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience

(2013) Audrey Coilly et al.   JOURNAL OF HEPATOLOGY

Current management and perspectives for HCV recurrence after liver transplantation

(2013) Audrey Coilly et al.   LIVER INTERNATIONAL

HCV direct-acting antiviral agents: the best interferon-free combinations

(2013) Raymond Schinazi et al.   LIVER INTERNATIONAL

Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation

(2013) Surakit Pungpapong et al.   LIVER TRANSPLANTATION

Practical Management of Boceprevir and Immunosuppressive Therapy in Liver Transplant Recipients with Hepatitis C Virus Recurrence

(2012) Audrey Coilly et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes

(2012) Patrizia Burra et al.   JOURNAL OF HEPATOLOGY

Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment

(2012) Marina Berenguer et al.   JOURNAL OF HEPATOLOGY

Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation

(2012) Robert J. Fontana et al.   LIVER TRANSPLANTATION

PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus

(2011) Natalie Bzowej et al.   LIVER TRANSPLANTATION

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin

(2008) Marina Berenguer   JOURNAL OF HEPATOLOGY

Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies

(2008) E. Xirouchakis et al.   JOURNAL OF VIRAL HEPATITIS